Microbiology and Molecular Biology Reviews, March 2006, p. 1-11, Vol. 70, No. 1
1092-2172/06/$08.00+0 doi:10.1128/MMBR.70.1.1-11.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
| INSTRUCTIONS TO AUTHORS |
SCOPE
SCOPE EDITORIAL POLICY Use of Microbiological Information General Requirements Supplemental Material Primary Publication Permissions Copyright Authorship Conflict of Interest Warranties and Exclusions Correspondent Footnote Errata Authors' Corrections Compliance Review Process Notification of Acceptance Page Proofs Reprints PDF Files Editorial Style HOW TO SUBMIT MANUSCRIPTS ORGANIZATION AND FORMAT References (i) Works listed in References. (ii) Items cited in the text. Abbreviations General. Not requiring introduction. Reporting Numerical Data Nomenclature ILLUSTRATIONS AND TABLES Illustrations File types and formats. Minimum resolution. Size. Contrast. Labeling and assembly. Fonts. Compression. Color illustrations. Drawings Tables Presentation of Nucleic Acid Sequences
Microbiology and Molecular Biology Reviews (MMBR) publishes reviews dealing with all aspects of microbiology and other fields of concern to microbiologists, such as immunology. Authoritative and critical reviews of the current state of knowledge are preferred, although historical analyses will be accepted if the importance of the subject justifies this approach. Unevaluated compilations of the literature and annotated bibliographies do not fall within the scope of MMBR. Manuscripts of lectures delivered at symposia and roundtables are likewise unacceptable; however, their authors are encouraged to discuss with the editor the possibility of using such material as the basis for preparation of a review when publication in this form seems appropriate. Because a distinct goal of the journal is to appeal to the interests of its diverse group of subscribers, authors are asked to address themselves to both specialists and generalists; this demands conscious concern for this goal in writing.
Manuscripts reach MMBR by one of two mechanisms. First, reviews are solicited by the editors from leading investigators around the world. Second, suggestions for reviews of subjects that have not been reviewed recently may be e-mailed to the MMBR editorial office (mmbr{at}bact.wisc.edu). Such suggestions should be accompanied by a summary; an annotated topical outline; a one- or two-paragraph statement describing the aim, scope, and relevance of the review; a list of key references showing the author's contributions to the field, as well as other investigators' findings; and a curriculum vitae and bibliography for each proposed author. Such outlines will be evaluated by the editors, and if the material is satisfactory, the authors will be invited to write the review and submit it via Rapid Review.
A review, whether invited or not, cannot be finally accepted until the finished product has been reviewed and found to be satisfactory.
ASM recognizes that there are valid concerns regarding the publication of information in scientific journals that could be put to inappropriate use as described in the CPC resolution mentioned above. Members of the ASM Publications Board will evaluate the rare manuscript that might raise such issues during the review process. However, as indicated elsewhere in these Instructions, research articles must contain sufficient detail, and material/information must be made available, to permit the work to be repeated by others. Supply of materials should be in accordance with laws and regulations governing the shipment, transfer, possession, and use of biological materials and must be for legitimate, bona fide research needs. Links to, and information regarding, these laws and regulations can be found at http://www.asm.org/Policy/index.asp.
All authors of a manuscript must have agreed to its submission and are responsible for its content (initial submission and any subsequent versions), including appropriate citations and acknowledgments, and must also have agreed that the corresponding author has the authority to act on their behalf in all matters pertaining to publication of the manuscript. The corresponding author is responsible for obtaining such agreements and for informing the coauthors of the manuscript's status throughout the submission, review, and publication processes. For Authors' Corrections, signed letters of agreement from all of the authors must be submitted (see p. 4).
It is expected that the authors will provide written assurance that permission to cite unpublished data or personal communications has been granted.
Supplemental material intended for posting by ASM must be uploaded in Rapid Review and will be reviewed along with the manuscript. The decision to publish (i.e., post online only) the material with the article if it is accepted will be made by the editor in chief and conveyed to the corresponding author in the acceptance e-mail. Note, therefore, it is possible that an article will be accepted but that the supplemental material will not be.
If the software required for users to view/use the supplemental material is not embedded in the file, you are urged to use shareware or generally available/easily accessible programs.
Unlike the article, supplemental material will not be edited by the ASM Journals staff and proofs will not be made available.
Supplemental material will always remain associated with its article and is not subject to any modifications after publication.
Material that has been published previously (print or online) is not acceptable for posting as supplemental data. Instead, the appropriate reference(s) to the original publication should be made in the article text.
Copyright for the supplemental material remains with the author, but a license permitting the posting by ASM will be sent, along with the article copyright transfer agreement, to the corresponding author for signing. If you are not the copyright owner, you must provide directly to the editor, outside the Rapid Review system and no later than the modification stage, signed permission from the owner that allows posting of the material, as a supplement to your article, by ASM. You are responsible for including in the supplemental material any copyright notices required by the owner.
Posting of a method/protocol on a nonpersonal website should not interfere with the author's ability to have a manuscript utilizing that technique considered for publication in an ASM journal; however, ultimately, it is an editorial decision whether the method constitutes the substance of a paper.
Posting of a limited amount of original data on a personal/university/company website or websites of small collaborative groups working on a problem does not preclude subsequent submission to, and publication by, an ASM journal. The posted data, however, may not constitute the substance of the submission. Specific questions about this policy may be referred to the Publications Board chairman on a case-by-case basis. Posting of theses and dissertations on a personal/university-hosted website does not preclude subsequent submission to, and publication by, an ASM journal.
Posting of unpublished sequence data on the Internet is usually not considered prior publication; however, the address (URL) of the source of the sequence should be included in the text.
Preliminary disclosures of research findings webcast as meeting presentations or published in abstract form as adjuncts to a meeting, e.g., part of a program, are not considered prior publication.
It is incumbent upon the author to acknowledge any prior publication, including his own articles, of the data contained in a manuscript submitted to an ASM journal. A copy of the relevant work should be submitted with the paper as supporting material.
Ultimately, it is an editorial decision whether the material constitutes the substance of a paper.
The original signed permission(s) must be submitted to the editor, outside the Rapid Review system, no later than the modification stage and should be identified as to the relevant item in the ASM manuscript (e.g., "permissions for Fig. 1 in submitted manuscript"). In addition, a statement indicating that the material is being reprinted with permission must be included in the relevant figure legend or table footnote of the manuscript. Reprinted text must be enclosed in quotation marks, and the permission statement must be included as running text or indicated parenthetically.
For supplemental material intended for posting by ASM (see above), if the authors of the MMBR manuscript are not also the owner of the supplemental material, the corresponding author must send directly to the editor, outside the Rapid Review system and no later than the modification stage, signed permission from the copyright owner that allows posting of the material, as a supplement to the article, by ASM. The corresponding author is also responsible for incorporating in the supplemental material any copyright notices required by the owner.
In the copyright transfer agreement signed by an author, ASM grants to that author (and coauthors) the right to republish discrete portions of his (their) article in any other publication (print, CD-ROM, and other electronic forms) of which he is (they are) the author(s) or editor(s), on the condition that appropriate credit is given to the original ASM publication. This republication right also extends to posting on a host computer to which there is access via the Internet. Except as indicated below, significant portions of the article may not be reprinted/posted without ASM's prior written permission, however, as this would constitute duplicate publication.
Authors may post their own published articles on their personal or university-hosted (but not corporate, government, or similar) websites without ASM's prior written permission provided that appropriate credit is given (i.e., either the copyright lines shown on the top of the first page of the PDF version or "Copyright © American Society for Microbiology, [insert journal name, volume number, page numbers, and year]" for the HTML version).
The copyright transfer agreement asks that authors who were U.S. Government employees and who wrote the article as part of their employment duties be identified. This is because works authored solely by such U.S. Government employees are not subject to copyright protection, so there is no copyright to be transferred. The other provisions of the copyright transfer agreement, such as author representations of originality and authority to enter into the agreement, apply to U.S. Government employee-authors as well as to other authors.
Copyright for supplemental material (see p. 1) remains with the author, but a license permitting the posting by ASM will be sent, along with the article copyright transfer agreement, to the corresponding author for signing at the acceptance stage. (If the author of the article is not also the copyright owner of the supplemental material, the corresponding author must send directly to the editor, outside the Rapid Review system and no later than the modification stage, signed permission from the owner that allows posting of the material, as a supplement to the article, by ASM. The corresponding author is also responsible for incorporating into the supplemental material any copyright notices required by the owner.)
A study group, surveillance team, working group, consortium, or the like (e.g., the Active Bacterial Core Surveillance Team) may be listed as a coauthor in the byline if its contributing members satisfy the requirements for authorship and accountability as described in these Instructions. The names (and institutional affiliations if desired) of the contributing members only may be given in a footnote keyed to the study group name in the byline or as a separate paragraph in the Acknowledgments section.
If the contributing members of the group associated with the work do not fulfill the criteria of substantial contribution to and responsibility for the paper, the group may not be listed in the author byline. Instead, it and the names of its contributing members may be listed in the Acknowledgments section.
All authors must agree to the order in which their names are listed in the byline. Statements regarding equal contributions by two or more authors (e.g., X.J. and Y.S. contributed equally to ...) are permitted as footnotes to bylines. Other statements of attribution may be included in the Acknowledgments section.
A change in authorship (order of listing or addition or deletion of a name) after submission of the manuscript will be implemented only after receipt of signed statements of agreement from all parties involved. Disputes about authorship may delay review and/or publication of the manuscript.
Details of the disclosure to the editor will remain confidential. However, it is the responsibility of authors to provide, in the Acknowledgments section, a general statement disclosing financial or other relationships that are relevant to the study. Examples of potentially conflicting interests that should be disclosed include relationships that might detract from an author's objectivity in presentation of study results, and interests whose value would be enhanced by the results presented. All funding sources for the project, institutional and corporate, should be credited in the Acknowledgments section. In addition, if a manuscript concerns a commercial product, the manufacturer's name must be indicated in the text in an obvious manner.
For omission of an author's name, the authors of the article and the author whose name was inadvertently omitted must agree, in writing, to publication of the Correction. For other issues involving authorship, including contributions and use or ownership of data and/or materials, all disputing parties must agree, in writing, to publication of the Correction. Copies of the agreement letters must accompany the Correction and be sent directly to the Journals Department. Send the Correction both on disk and in hard copy (only one hard copy is necessary). Please see a recent issue for correct formatting.
Corrections of a scientific nature (e.g., an incorrect unit of measurement or order of magnitude used throughout; contamination of one of numerous cultures; misidentification of a mutant strain, causing erroneous data for only a portion [noncritical] of the study) must be sent, both on disk and in hard copy, directly to the editor in chief and must be accompanied by signed letters of agreement from all of the authors of the article. If the editor in chief believes that publication is warranted, he will send the Correction to the Journals Department for publication. Note that the addition of new data is not permitted.
Copies of in-press and submitted manuscripts that are important for judgment of the present manuscript should be included as supporting material to facilitate the review.
When a manuscript is submitted to the journal, it is given a number (e.g., MMBR00047-06 version 1) and assigned to the editor in chief. (Always refer to this number in communications with the editor and the Journals Department.) It is the responsibility of the corresponding author to inform the coauthors of the manuscript's status throughout the submission, review, and publication processes. The reviewers operate under strict guidelines set forth in "Guidelines for Reviewers" (http://www.journals.asm.org/misc/reviewguide.shtml) and are expected to complete their reviews expeditiously.
The corresponding author is notified by the editor in chief of her decision to accept, reject, or require modification. When modification is requested, the corresponding author must either submit the modified version within 2 to 3 months or withdraw the manuscript. A point-by-point response to the reviews must be provided in the Rebuttal section of the Rapid Review submission form for the revised manuscript, and a compare copy of the manuscript (without figures) should be included as supporting material if the editor in chief requested one.
Manuscripts that have been rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission. The former manuscript number should be provided in the appropriate field on the submission form. A point-for-point response to the reviews and a compare copy of the revised manuscript showing the changes must be included as supporting material (the Rebuttal section appears in the submission form only if the manuscript is a modification). Rejected manuscripts may be resubmitted only once unless permission has been obtained from the editor in chief.
Once all the material intended for publication has been determined to be adequate, the manuscript is scheduled for the next available issue and an acceptance letter indicating the month of publication and approximate page proof dates is mailed to the corresponding author; a copyright transfer agreement is also included, as is a license to permit posting of supplemental material (if applicable). The editorial staff of the ASM Journals Department completes the editing of the manuscript to bring it into conformity with prescribed standards.
The proof stage is not the time to make extensive corrections, additions, or deletions. Important new information that has become available between acceptance of the manuscript and receipt of the proofs may be inserted as an addendum in proof with the permission of the editor in chief. If references to unpublished data or personal communications are added, it is expected that written assurance granting permission for the citation will be provided. Limit changes to correction of spelling errors, incorrect data, and grammatical errors and updated information for references to articles that have been submitted or are in press. If URLs have been provided in the article, recheck the sites to ensure that the addresses are still accurate and the material that you expect the reader to find is indeed there.
Questions about late proofs and problems in the proofs should be directed to the ASM Journals Department (telephone, 202-942-9231). Questions about accessing or viewing your PDF proofs should be directed to Katie Gay of Cadmus Professional Communications at 804-261-3155 or gayk{at}cadmus.com.
Should coauthors or colleagues be interested in viewing the paper for their own use, the corresponding author may provide them with the URL; a copy of the article may not be forwarded electronically. However, they must be made aware of the terms and conditions of the ASM copyright. (For details, go to http://www.journals.asm.org/misc/terms.shtml.) Note that each such download will count toward the corresponding author's total of 10. After 10 downloads, access will be denied and can be obtained only through a subscription to the journal (either individual or institutional) or after the standard access control has been lifted (i.e., 1 year after publication).
The editorial style of ASM journals conforms to the ASM Style Manual for Journals (American Society for Microbiology, 2006, in-house document) and How To Write and Publish a Scientific Paper, 5th ed. (Oryx Press, 1998), as interpreted and modified by the editors and the ASM Journals Department.
The editors and the Journals Department reserve the privilege of editing manuscripts, whether invited or not, to conform with the stylistic conventions set forth in the aforesaid publications and in these Instructions. Any deviations from this style must be approved by the Journals Department.
All submissions to MMBR must be made electronically via the Rapid Review online submission and peer review system at the following URL: www.rapidreview.com/ASM2/author.html. (E-mailed submissions will not be accepted.) For solicited reviews, the name of the editor who invited the submission must be specified in the cover letter. First-time users must create an Author account, which may be used for submitting to all ASM journals. Instructions for creating an Author account are available at the above URL under the Create Account button. The person from whose account a submission is made will be recorded as the corresponding author, and any correspondence will be sent to the e-mail address in that account. Step-by-step instructions for submitting a manuscript via Rapid Review are available from the account holder's My Manuscripts page. Information on file types acceptable for electronic submission can be found under the More About File Formats button.
On receipt at ASM, the electronic file of an accepted manuscript undergoes an automated preediting, cleanup, and tagging process specific to the particular article type. To optimize this process, manuscripts must be supplied in the correct format and with the appropriate section headings. Consult a recent issue of MMBR for format and style. The title page must include the title, the running title (not to exceed 54 characters and spaces), the name and affiliation of each author, and a footnote indicating the complete mailing address, telephone number, fax number and e-mail address of the corresponding author. A table of contents showing the major headings and subheadings of the text should follow the title page. Headings and subheadings have the following format:
LEVEL 1 HEAD
Level 2 Head
Level 3 head. (i) Level 4 head. (a) Level 5 head.
The summary, which will be included in the issue table of contents and must be no longer than 250 words, should be placed at the end of the electronic file, after the References section and the figure legends (but before any tables).
Type every portion of the manuscript double spaced (a minimum of 6 mm between lines), including figure legends, table footnotes, and References, and number all pages in sequence, including the figure legends and tables. Place the last two items after the References section. Manuscript pages should have line numbers; manuscripts without line numbers may be editorially rejected by the editor, with a suggestion of resubmission after line numbers are added. The font size should be no smaller than 12 points. It is recommended that the following sets of characters be easily distinguishable in the manuscript: the numeral zero (0) and the letter "oh" (O); the numeral one (1), the letter "el" (l), and the letter "eye" (I); and a multiplication sign (x) and the letter "ex" (x). Do not create symbols as graphics or use special fonts that are external to your word processing program; use the "insert symbol" function. Set the page size to 8
by 11 inches (ca. 21.6 by 28 cm). Italicize or underline any words that should appear in italics, and indicate paragraph lead-ins in bold type.
Authors who are unsure of proper English usage should have their manuscripts checked by someone proficient in the English language.
Manuscripts may be editorially rejected, without review, on the basis of poor English or lack of conformity to the standards set forth in these Instructions.
Follow the styles shown in the examples below.
Print references:
*A reference to an in-press ASM publication should state the control number (e.g., JB00577-06) if it is a journal article or the name of the publication if it is a book.
Online references:
NOTE: A URL or DOI is necessary for each online-only reference; a posting or accession date is required for any online reference that is periodically updated or changed.
(ii) Items cited in the text. References to meeting abstracts (including those published in journal supplements), letters (irrespective of type) and authors' replies to letters, company publications, patent applications and patents pending, computer software, databases, and websites should be made parenthetically in the text as follows.
... similar results (R. B. Layton and C. C. Weathers, unpublished data).
... system was used (J. L. McInerney, A. F. Holden, and P. N. Brighton, submitted for publication).
... in mitochondria (S. De Wit, C. Thioux, and N. Clumeck, Abstr. 34th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 114, 1994).
... for other bacteria (A. X. Jones, personal communication.
... discussed previously (L. B. Jensen, A. M. Hammerum, R. L. Poulsen, and H. Westh, Letter, Antimicrob. Agents Chemother. 43:724-725, 1999).
... discussed previously (S. L. W. On and P. A. R. Vandamme, Authors' Reply to Letter, J. Clin. Microbiol. 39:2751-2752, 2001).
... the manufacturer (Sigma manual, Sigma Chemical Co., St. Louis, Mo.).
... this process (V. R. Smoll, 20 June 1999, Australian Patent Office). {For non-U.S. patent applications, give the date of publication of the application.}
... information found at the XYZ website (http://cbx_iou.pgr).
... the ABC program (version 2.2; Department of Microbiology, State University [http://www.stu.micro]).
URLs for companies that produce any of the products mentioned in your study or for products being sold may NOT be included in the article. However, company URLs that permit access to scientific data related to the study or to shareware used in the study are permitted.
If any reference(s) must be moved from the References section to the text to conform to ASM style, the numbered reference (byline, title, etc.) will be replaced with the words "Reference deleted" in order to preserve the author's original numbering sequence and to avoid excessive renumbering.
Not requiring introduction. In addition to abbreviations for Système International d'Unités (SI) units of measurement, other common units (e.g., bp, kb, and Da), and chemical symbols for the elements, the following should be used without definition in the title, summary, text, figure legends, and tables: DNA (deoxyribonucleic acid); cDNA (complementary DNA); RNA (ribonucleic acid); cRNA (complementary RNA); RNase (ribonuclease); DNase (deoxyribonuclease); rRNA (ribosomal RNA); mRNA (messenger RNA); tRNA (transfer RNA); AMP, ADP, ATP, dAMP, ddATP, GTP, etc. (for the respective 5' phosphates of adenosine and other nucleosides) (add 2'-, 3'-, or 5'- when needed for contrast); ATPase, dGTPase, etc. (adenosine triphosphatase, deoxyguanosine triphosphatase, etc.); NAD (nicotinamide adenine dinucleotide); NAD+ (nicotinamide adenine dinucleotide, oxidized); NADH (nicotinamide adenine dinucleotide, reduced); NADP (nicotinamide adenine dinucleotide phosphate); NADPH (nicotinamide adenine dinucleotide phosphate, reduced); NADP+ (nicotinamide adenine dinucleotide phosphate, oxidized); poly(A), poly(dT), etc. (polyadenylic acid, polydeoxythymidylic acid, etc.); oligo(dT), etc. (oligodeoxythymidylic acid, etc.); UV (ultraviolet); PFU (plaque-forming units); CFU (colony-forming units); MIC (minimal inhibitory concentration); Tris [tris(hydroxymethyl)aminomethane]; DEAE (diethylaminoethyl); EDTA (ethylenediaminetetraacetic acid); EGTA [ethylene glycol-bis(ß-aminoethyl ether)N,N,N',N'-tetraacetic acid]; HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid); PCR (polymerase chain reaction); and AIDS (acquired immunodeficiency syndrome). Abbreviations for cell lines (e.g., HeLa) also need not be defined.
The following abbreviations should be used without definition in tables:
When fractions are used to express units such as enzymatic activities, it is preferable to use whole units, such as "g" or "min," in the denominator instead of fractional or multiple units, such as µg or 10 min. For example, "pmol/min" is preferable to "nmol/10 min," and "µmol/g" is preferable to "nmol/µg." It is also preferable that an unambiguous form such as exponential notation be used; for example, "µmol g1 min1" is preferable to "µmol/g/min." Always report numerical data in the applicable SI units.
For a review of some common errors associated with statistical analyses and reports, plus guidelines on how to avoid them, see the article by Olsen (Infect. Immun. 71:6689-6692, 2003).
For a review of basic statistical considerations for virology experiments, see the article by Richardson and Overbaugh (J. Virol. 79:669-676, 2005).
Names used for viruses should be those approved by the International Committee on Taxonomy of Viruses (ICTV) and published in Virus Taxonomy: Classification and Nomenclature of Viruses, Seventh Report of the International Committee on Taxonomy of Viruses (M. H. V. van Regenmortel et al., ed., Academic Press, San Diego, Calif., 2000). In addition, the recommendations of the ICTV regarding the use of species names should generally be followed: when the entire species is discussed as a taxonomic entity, the species name, like other taxa, is italic and has the first letter and any proper nouns capitalized (e.g., Tobacco mosaic virus, Murray Valley encephalitis virus). When the behavior or manipulation of individual viruses is discussed, the vernacular (e.g., tobacco mosaic virus, Murray Valley encephalitis virus) should be used. If desired, synonyms may be added parenthetically when the name is first mentioned. Approved generic (or group) and family names may also be used.
For enzymes, use the recommended (trivial) name assigned by the Nomenclature Committee of the IUB as described in Enzyme Nomenclature (Academic Press, Inc., New York, N.Y., 1992) and at http://www.chem.qmul.ac.uk/iubmb/enzyme/.
For nomenclature of restriction enzymes, DNA methyltransferases, homing endonucleases, and their genes, refer to the article by Roberts et al. (Nucleic Acids Res. 31:1805-1812, 2003).
Genetic nomenclature should essentially follow the recommendations of Demerec et al. (Genetics 54:61-76, 1966) and those given in the instructions to authors of the Journal of Bacteriology and Molecular and Cellular Biology (January issues) and Eukaryotic Cell (February issue). To facilitate accurate communication, it is important that standard genetic nomenclature be used whenever possible and that deviations or proposals for new naming systems be endorsed by an appropriate authoritative body. Review and/or publication of submitted manuscripts that contain new or nonstandard nomenclature may be delayed by the editor or the Journals Department so that they may be reviewed by the Genetics and Genomics Committee of the ASM Publications Board.
Before submission of manuscripts, authors may direct questions on genetic nomenclature to the committee's chairman: Maria Costanzo (e-mail: maria{at}genome.stanford.edu). Such a consultation should be mentioned in the manuscript submission letter.
Digital files that are acceptable for production (see below) must be provided for all illustrations on return of the modified manuscript. (On initial submission, the entire paper may be submitted in PDF format.)
We strongly recommend that before returning their modified manuscripts, authors check the acceptability of their digital images for production by running their files through Rapid Inspector, a tool provided at the following URL: http://rapidinspector.cadmus.com/mw/. Rapid Inspector is an easy-to-use Web-based application that identifies file characteristics that may render the image unusable for production.
Illustrations may be continuous-tone images, line drawings, or composites. Suggestions about how to ensure accurate color reproduction are given below.
The preferred format for tables is MS Word; however, WordPerfect and Acrobat PDF are also acceptable (see the section on Tables below).
Since the contents of computer-generated images can be manipulated for better clarity, the Publications Board at its May 1992 meeting mandated that a description of the software/hardware used should be put in the figure legend(s).
|
View this table: [in a new window] |
Macintosh
|
|
View this table: [in a new window] |
Windows
|
Size. All graphics MUST be submitted at their intended publication size; that is, the image uploaded should be 100% of its print dimensions so that no reduction or enlargement is necessary. Resolution must be at the required level at the submitted size. Include only the significant portion of an illustration. White space must be cropped from the image, and excess space between panel labels and the image must be eliminated.
inches (ca. 8.4 cm)
inches (ca. 17.4 cm)
inches (10.8 cm)
inches (23.0 cm) Contrast. Illustrations must contain sufficient contrast to withstand the inevitable loss of contrast and detail inherent in the printing process. See also the section on color illustrations below.
Labeling and assembly. All final lettering, labeling, tooling, etc., MUST be incorporated into the figures. It cannot be added at a later date. If a figure number is included, it must appear well outside the boundaries of the image itself. (Numbering may need to be changed at the copyediting stage.) Each figure must be uploaded as a separate file, and any multipanel figures must be assembled into one file; i.e., rather than sending a separate file for each panel in a figure, assemble all panels in one piece and supply them as one file.
Fonts. To avoid font problems, set all type in one of the following fonts: Helvetica, Times Roman, European PI, Mathematical PI, or Symbol. All fonts other than these five must be converted to paths (or outlines) in the application with which they were created. For font use in PowerPoint images, refer to the Cadmus digital art website, http://cjs.cadmus.com/da.
Compression. Images created with Macintosh applications may be compressed with Stuffit. Images created with Windows applications may be compressed with WINZIP or PKZIP.
Color illustrations. Because the process of placing ink on paper by using printing presses is different from that used to produce a photo print or a laser print and the color rendition on images viewed on a monitor depends to some extent on monitor resolution, some differences in color and contrast between the image you submit and the image printed in the journal or published online will be evident. (Figures showing red or green fluorescence and those with a significant range of colors may be difficult or impossible to reproduce exactly.) Color illustrations must be saved as either TIFF or EPS files, according to the application used (see charts above). The mode of the TIFF or EPS file must be CMYK, not RGB. Graphics in the RGB color space are intended for display on a monitor only and will not separate correctly for printing.
Adherence to the following guidelines, in addition to the general ones above, will help to ensure color reproduction that is as accurate as possible. Include only the significant portions of illustrations so that the number of printed pages containing color figures is minimized. The individual panels of a single figure must be assembled in a single file, including any necessary labels. Optimal color reproduction will be obtained if the composites comprise panels containing similar colors of similar lightness or darkness. If necessary, make unlike panels into separate figures/files; the color rendition will be more accurate since the two panels will be "scanned" separately.
When creating line art, please use the following guidelines:
In figure ordinate and abscissa scales (as well as table column headings), avoid the ambiguous use of numbers with exponents. Usually, it is preferable to use the Système International d'Unités (SI) symbols (µ for 106, m for 103, k for 103, M for 106, etc.). A complete listing of SI symbols can be found in the International Union of Pure and Applied Chemistry (IUPAC) "Manual of Symbols and Terminology for Physicochemical Quantities and Units" (Pure Appl. Chem. 21:3-44, 1970). Thus, a representation of 20,000 cpm on a figure ordinate is to be made by the number 20 accompanied by the label kcpm.
When powers of 10 must be used, the journal requires that the exponent power be associated with the number shown. In representing 20,000 cells per ml, the numeral on the ordinate would be "2" and the label would be "104 cells per ml" (not "cells per ml x 104"). Likewise, an enzyme activity of 0.06 U/ml would be shown as 6 accompanied by the label 102 U/ml. The preferred designation would be 60 mU/ml (milliunits per milliliter).
Tables should be formatted as follows. Arrange the data so that columns of like material read down, not across. The headings should be sufficiently clear so that the meaning of the data is understandable without reference to the text. See the Abbreviations section (p. 7) of these Instructions for those that should be used in tables. Explanatory footnotes are acceptable, but more extensive table "legends" are not. Footnotes should not include detailed descriptions of the experiment. Tables must include enough information to warrant table format; those with fewer than six pieces of data will be incorporated into the text by the copy editor. Table 1 is an example of a well-constructed table.
|
View this table: [in a new window] |
TABLE 1 Partial restoration of NO production by exogenous TNF- in cytochalasin B-inhibited macrophages treated with GBS and IFN
|
* Shading indicates material that has been added or significantly updated. ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»